Literature DB >> 23147085

Multicentre study of circumferential margin positivity and outcomes following abdominoperineal excision for rectal cancer.

R P Kennelly1, A C Rogers, D C Winter.   

Abstract

BACKGROUND: Rectal cancer outcomes following abdominoperineal excision (APE) have been inferior to those for anterior resection, including more positive circumferential resection margins (CRMs). An erroneously conservative interpretation of APE (rather than a radical resection termed 'extralevator') has been proposed as the cause. In this multicentre study, factors contributing to CRM positivity were examined following APE according to its original description.
METHODS: Data were collected from five hospital databases up to June 2011 including small- and larger-volume units (3 hospitals had 5 or fewer and 2 hospitals had more than 5 APE procedures per year). Primary outcome measures were CRM status; secondary outcomes were local recurrence and death.
RESULTS: Of 327 patients, 302 patients had complete data for analysis. Some 50·0 per cent of patients had neoadjuvant chemoradiotherapy. Histopathological examination showed that 62·9 per cent had tumour category T3 or T4 cancers, 42·1 per cent had node-positive disease and the CRM positivity rate was 13·9 per cent. Multivariable analysis showed only pathological tumour category pT4 (odds ratio 19·92, 95 per cent confidence interval 6·48 to 68·61) and node positivity (odds ratio 3·04, 1·32 to 8·05) to be risk factors for a positive circumferential margin. CRM positivity was a risk factor for local recurrence (P = 0·022) and decreased overall survival (P = 0·001). Hospital volume had no impact on the likelihood of CRM positivity (P = 0·435).
CONCLUSION: In patients undergoing APE by appropriately trained surgeons using a standardized approach, margin positivity was dictated by tumour stage, but not by centre or surgeon.
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23147085     DOI: 10.1002/bjs.9001

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  16 in total

1.  Extralevator Abdominal Perineal Excision Versus Standard Abdominal Perineal Excision: Impact on Quality of the Resected Specimen and Postoperative Morbidity.

Authors:  Angelita Habr-Gama; Guilherme P São Julião; Adrian Mattacheo; Luiz Felipe de Campos-Lobato; Edgar Aleman; Bruna B Vailati; Joaquim Gama-Rodrigues; Rodrigo Oliva Perez
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

2.  Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis.

Authors:  Ao Huang; Hongchao Zhao; Tianlong Ling; Yingjun Quan; Minhua Zheng; Bo Feng
Journal:  Int J Colorectal Dis       Date:  2014-01-03       Impact factor: 2.571

3.  Long-term outcome of extralevator abdominoperineal excision (ELAPE) for low rectal cancer.

Authors:  Sigmar Stelzner; Gunter Hellmich; Anja Sims; Thomas Kittner; Eric Puffer; Joerg Zimmer; Dorothea Bleyl; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2016-09-09       Impact factor: 2.571

Review 4.  [Evidence-based surgery of rectal cancer].

Authors:  M Grade; H Flebbe; B M Ghadimi
Journal:  Chirurg       Date:  2019-05       Impact factor: 0.955

5.  Laparoscopic translevator approach to abdominoperineal resection for rectal adenocarcinoma: feasibility and short-term oncologic outcomes.

Authors:  Vanessa N Palter; Steven MacLellan; Shady Ashamalla
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

6.  A comparison of the technical and oncologic validity between robot-assisted and conventional open abdominoperineal resection.

Authors:  Jin C Kim; Jae Y Kwak; Yong S Yoon; In J Park; Chan W Kim
Journal:  Int J Colorectal Dis       Date:  2014-06-10       Impact factor: 2.571

7.  Outcome of extralevator abdominoperineal excision over conventional abdominoperineal excision for low rectal tumor: a meta-analysis.

Authors:  Yue Yang; Huirong Xu; Zhenhua Shang; Shouzhen Chen; Fan Chen; Qiming Deng; Li Luo; Liang Zhu; Benkang Shi
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 8.  Surgery for rectal cancer-what is on the horizon?

Authors:  Thomas A Vermeer; Ricardo G Orsini; Harm J T Rutten
Journal:  Curr Oncol Rep       Date:  2014-03       Impact factor: 5.075

9.  Pattern of rectal cancer recurrence after curative surgery.

Authors:  Minna Räsänen; Monika Carpelan-Holmström; Harri Mustonen; Laura Renkonen-Sinisalo; Anna Lepistö
Journal:  Int J Colorectal Dis       Date:  2015-03-22       Impact factor: 2.571

Review 10.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.